Metropolis Healthcare Ltd.

NSE: METROPOLIS | BSE: 542650 | ISIN: INE112L01020 | Industry: Healthcare Services
| Momentum Trap

2133.60
4.22%
Emkay
MHL’s Q3FY25 EBITDA missed street/our estimates by 9%/4%, with revenue growing 11% YoY driven by B2C revenue improving 15% YoY.
Metropolis Healthcare Ltd.'s price crossed above 50Day SMA today
More from Metropolis Healthcare Ltd.
Recommended